HCA Healthcare Inc.

AI Score

XX

Unlock

345.23
3.07 (0.90%)
At close: Mar 31, 2025, 9:53 AM

Company Description

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.

The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.

In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services.

As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England.

The company was formerly known as HCA Holdings, Inc.

HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Inc.
HCA Healthcare Inc. logo
Country United States
IPO Date Mar 10, 2011
Industry Medical - Care Facilities
Sector Healthcare
Employees 226,000
CEO Samuel N. Hazen

Contact Details

Address:
One Park Plaza
Nashville, Tennessee
United States
Website https://www.hcahealthcare.com

Stock Details

Ticker Symbol HCA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000860730
CUSIP Number 40412C101
ISIN Number US40412C1018
Employer ID 27-3865930
SIC Code 8062

Key Executives

Name Position
Samuel N. Hazen Chief Executive Officer & Director
Chad J. Wasserman Senior Vice President & Chief Information Officer
Jon Mack Foster Executive Vice President & Chief Operating Officer
Michael A. Marks Chief Financial Officer & Executive Vice President
Christopher F. Wyatt Senior Vice President, Principal Accounting Officer & Controller
Dr. Michael S. Cuffe M.B.A., M.D. Executive Vice President & Chief Clinical Officer
Dr. Thomas F. Frist Jr., M.D. Founder & Chairman Emeritus
Frank George Morgan C.F.A. Vice President of Investor Relations
Michael R. McAlevey Executive Vice President and Chief Legal & Administrative Officer
Wendy Warren Senior Vice President, Chief Ethics & Compliance Officer

Latest SEC Filings

Date Type Title
Mar 28, 2025 4 Filing
Mar 14, 2025 ARS Filing
Mar 14, 2025 DEFA14A Filing
Mar 14, 2025 DEF 14A Filing
Mar 04, 2025 PRE 14A Filing
Feb 24, 2025 8-K Current Report
Feb 21, 2025 8-K Current Report
Feb 20, 2025 8-K Current Report
Feb 20, 2025 424B5 Filing
Feb 19, 2025 FWP Filing